In cancer, there is upregulation of PD-L1 expression on tumour cells, which causes T-cell suppression, and this impedes antitumour immunity, promotes immune tumour cell evasion, and enhances tumour survival [13]. This evidence concerns the gene CD274 and neoplasm.